ENGOT-EN9/LEAP-001: A PHASE 3 STUDY OF FIRST-LINE PEMBROLIZUMAB PLUS LENVATINIB COMPARED WITH CHEMOTHERAPY IN ADVANCED OR RECURRENT ENDOMETRIAL CANCER

Simple item page
dc.contributor.authorRandall, L.
dc.contributor.authorMarth, C.
dc.contributor.authorVulsteke, C.
dc.contributor.authorRubio, M. Jesus
dc.contributor.authorMakker, V.
dc.contributor.authorBraicu, I.
dc.contributor.authorMcNeish, I.
dc.contributor.authorMadry, R.
dc.contributor.authorAyhan, A.
dc.contributor.authorHasegawa, K.
dc.contributor.authorWu, X.
dc.contributor.authorDutta, L.
dc.contributor.authorXu, C.
dc.contributor.authorKeefe, S.
dc.contributor.authorLee, J.
dc.contributor.authorPignata, S.
dc.date.accessioned2021-03-19T06:59:48Z
dc.date.available2021-03-19T06:59:48Z
dc.date.issued2020
dc.identifier.endpageA130en_US
dc.identifier.issn1048-891Xen_US
dc.identifier.startpageA130en_US
dc.identifier.urihttp://hdl.handle.net/11727/5566
dc.identifier.volume30en_US
dc.identifier.wos000616549600276en_US
dc.language.isoengen_US
dc.relation.journalINTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCERen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titleENGOT-EN9/LEAP-001: A PHASE 3 STUDY OF FIRST-LINE PEMBROLIZUMAB PLUS LENVATINIB COMPARED WITH CHEMOTHERAPY IN ADVANCED OR RECURRENT ENDOMETRIAL CANCERen_US
dc.typeConference Objecten_US

Files

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

Tıp Fakültesi / Faculty of Medicine
Wos İndeksli Yayınlar Koleksiyonu
Wos Kapalı Erişimli Yayınlar